Increased Demand for Sleep Devices Spurs ResMed Growth
ResMed attributed the growth to increased demand for sleep devices, as well as strong growth across its mask product portfolio.
Stay updated with breaking news from Mike Fliss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ResMed attributed the growth to increased demand for sleep devices, as well as strong growth across its mask product portfolio.
Year-over-year revenue grows 12%, operating profit down 2%, non-GAAP operating profit up 20%Resumed share repurchase program, repurchased $50 million during quarter Note: A webcast of ResMed’s...
ResMed will reduce its workforce by 5 percent. Additionally, its leadership structure has changed with new roles and two executive departures.
ResMed announced a new operating model to accelerate long-term growth, which introduces new leadership to the global executive team.
ResMed (NYSE: RMD) announced that it's implementing a new operating model in an effort to to accelerate long-term growth.